Skip to main content
Erschienen in: International Urogynecology Journal 3/2013

01.03.2013 | Original Article

Comparison of diary-derived bladder and sleep measurements across OAB individuals, primary insomniacs, and healthy controls

verfasst von: Xavier A. Preud’homme, Cindy L. Amundsen, George D. Webster, Andrew D. Krystal

Erschienen in: International Urogynecology Journal | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

Can diary-derived bladder and sleep measurements differentiate individuals with overactive bladder syndrome (OAB) from individuals with primary insomnia and healthy controls?

Methods

Bladder- and sleep-diary data were compared in nine OAB, ten insomnia, and five control individuals. One-way analysis of variance (ANOVA) was used for normally and Kruskal–Wallis test for nonnormally distributed variables, followed, when significant effects were found, by pairwise comparisons.

Results

OAB individuals woke up as frequently as insomniacs, but their awakenings were respectively shorter in duration (18.6 vs. 38.1 min.) and were predominantly initiated by nocturic events (89.2 vs. 23.9 % respectively). Regardless, their reported quality of sleep was as impaired as for the insomniacs. Furthermore, smaller mean volume voided awakenings were evident not only in those with OAB but also in insomniacs compared to controls.

Conclusions

Bladder- and sleep-diary data provide means to differentiate those with OAB from those with insomnia and healthy controls. Awakenings in OAB individuals were shorter than those with insomnia and much more likely due to the need to void. Thus, a reduction in the number of nocturic voids could be the most appropriate sleep-related outcome for nocturia therapy in individuals with OAB. In addition, limited nocturnal bladder capacity, though expected in OAB, was unexpectedly found in insomnia, possibly reflecting the role of consciousness (wakefulness at night) in modulating bladder sensation.
Literatur
1.
Zurück zum Zitat Abrams P, Cardozo L, Fall M et al (2002) The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Am J Obstet Gynecol 187:116–126PubMedCrossRef Abrams P, Cardozo L, Fall M et al (2002) The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Am J Obstet Gynecol 187:116–126PubMedCrossRef
2.
Zurück zum Zitat Stewart WF, Van Rooyen JB, Cundiff GW et al (2003) Prevalence and burden of overactive bladder in the United States. World J Urol 20:327–336PubMed Stewart WF, Van Rooyen JB, Cundiff GW et al (2003) Prevalence and burden of overactive bladder in the United States. World J Urol 20:327–336PubMed
3.
Zurück zum Zitat Brown JS, McGhan WF, Chokroverty S (2000) Comorbidities associated with overactive bladder. Am J Manag Care 6:S574–S579PubMed Brown JS, McGhan WF, Chokroverty S (2000) Comorbidities associated with overactive bladder. Am J Manag Care 6:S574–S579PubMed
4.
Zurück zum Zitat Ganz ML, Smalarz AM, Krupski TL et al (2010) Economic costs of overactive bladder in the United States. Urology 75(526–532):532 Ganz ML, Smalarz AM, Krupski TL et al (2010) Economic costs of overactive bladder in the United States. Urology 75(526–532):532
5.
Zurück zum Zitat van Kerrebroeck P, Abrams P, Chaikin D et al (2002) The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21:179–183PubMedCrossRef van Kerrebroeck P, Abrams P, Chaikin D et al (2002) The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21:179–183PubMedCrossRef
6.
Zurück zum Zitat Middelkoop HAM, SmildevandenDoel DA, Neven AK, Kamphuisen HA, Springer CP (1996) Subjective sleep characteristics of 1,485 males and females aged 50–93: effects of sex and age, and factors related to self-evaluated quality of sleep. J Gerontol Ser A-Biol Sci Med Sci 51:M108–M115CrossRef Middelkoop HAM, SmildevandenDoel DA, Neven AK, Kamphuisen HA, Springer CP (1996) Subjective sleep characteristics of 1,485 males and females aged 50–93: effects of sex and age, and factors related to self-evaluated quality of sleep. J Gerontol Ser A-Biol Sci Med Sci 51:M108–M115CrossRef
7.
Zurück zum Zitat Bing MH, Moller LA, Jennum P, Mortensen S, Skovgaard LT, Lose G (2006) Prevalence and bother of nocturia, and causes of sleep interruption in a Danish population of men and women aged 60–80 years. BJU Int 98:599–604PubMedCrossRef Bing MH, Moller LA, Jennum P, Mortensen S, Skovgaard LT, Lose G (2006) Prevalence and bother of nocturia, and causes of sleep interruption in a Danish population of men and women aged 60–80 years. BJU Int 98:599–604PubMedCrossRef
8.
Zurück zum Zitat Foley DJ, Vitiello MV, Bliwise DL et al (2007) Frequent napping is associated with excessive daytime sleepiness, depression, pain, and nocturia in older adults: findings from the National Sleep Foundation ‘2003 Sleep in America' Poll. Am J Geriatr Psychiatry 15:344–350PubMedCrossRef Foley DJ, Vitiello MV, Bliwise DL et al (2007) Frequent napping is associated with excessive daytime sleepiness, depression, pain, and nocturia in older adults: findings from the National Sleep Foundation ‘2003 Sleep in America' Poll. Am J Geriatr Psychiatry 15:344–350PubMedCrossRef
9.
Zurück zum Zitat Bliwise DL, Foley DJ, Vitiello MV et al (2009) Nocturia and disturbed sleep in the elderly. Sleep Med 10:540–548PubMedCrossRef Bliwise DL, Foley DJ, Vitiello MV et al (2009) Nocturia and disturbed sleep in the elderly. Sleep Med 10:540–548PubMedCrossRef
10.
Zurück zum Zitat Harpe SE, Szeinbach SL, Caswell RJ, Corey R, McAuley JW (2007) The relative importance of health related quality of life and prescription insurance coverage in the decision to pharmacologically manage symptoms of overactive bladder. J Urol 178:2532–2536PubMedCrossRef Harpe SE, Szeinbach SL, Caswell RJ, Corey R, McAuley JW (2007) The relative importance of health related quality of life and prescription insurance coverage in the decision to pharmacologically manage symptoms of overactive bladder. J Urol 178:2532–2536PubMedCrossRef
11.
Zurück zum Zitat Weiss JP, Blaivas JG, Bliwise DL et al (2011) The evaluation and treatment of nocturia: a consensus statement. BJU Int 108:6–21PubMedCrossRef Weiss JP, Blaivas JG, Bliwise DL et al (2011) The evaluation and treatment of nocturia: a consensus statement. BJU Int 108:6–21PubMedCrossRef
12.
Zurück zum Zitat Homma Y, Yamaguchi O, Hayashi K, Neurogenic Bladder Society C, Homma Y, Yamaguchi O, Hayashi K (2005) An epidemiological survey of overactive bladder symptoms in Japan. BJU Int 96:1314–1318PubMedCrossRef Homma Y, Yamaguchi O, Hayashi K, Neurogenic Bladder Society C, Homma Y, Yamaguchi O, Hayashi K (2005) An epidemiological survey of overactive bladder symptoms in Japan. BJU Int 96:1314–1318PubMedCrossRef
13.
Zurück zum Zitat Brubaker L, FitzGerald MP (2007) Nocturnal polyuria and nocturia relief in patients treated with solifenacin for overactive bladder symptoms. Int Urogynecol J Pelvic Floor Dysfunct 18:737–741PubMedCrossRef Brubaker L, FitzGerald MP (2007) Nocturnal polyuria and nocturia relief in patients treated with solifenacin for overactive bladder symptoms. Int Urogynecol J Pelvic Floor Dysfunct 18:737–741PubMedCrossRef
14.
Zurück zum Zitat Staskin D, Michel MC, Nitti V et al (2010) Efficacy of fesoterodine over 24 hours in individuals with overactive bladder. Curr Med Res Opin 26:813–818PubMedCrossRef Staskin D, Michel MC, Nitti V et al (2010) Efficacy of fesoterodine over 24 hours in individuals with overactive bladder. Curr Med Res Opin 26:813–818PubMedCrossRef
15.
Zurück zum Zitat Kelleher CJ, Cardozo L, Chapple CR, Haab F, Ridder AM (2005) Improved quality of life in patients with overactive bladder symptoms treated with solifenacin. BJU Int 95:81–85PubMedCrossRef Kelleher CJ, Cardozo L, Chapple CR, Haab F, Ridder AM (2005) Improved quality of life in patients with overactive bladder symptoms treated with solifenacin. BJU Int 95:81–85PubMedCrossRef
16.
Zurück zum Zitat Garely AD, Lucente V, Vapnek J, Smith N (2007) Solifenacin for overactive bladder with incontinence: symptom bother and health-related quality of life outcomes. Ann Pharmacother 41:391–398PubMedCrossRef Garely AD, Lucente V, Vapnek J, Smith N (2007) Solifenacin for overactive bladder with incontinence: symptom bother and health-related quality of life outcomes. Ann Pharmacother 41:391–398PubMedCrossRef
17.
Zurück zum Zitat Yokoyama O, Yamaguchi O, Kakizaki H et al (2011) Efficacy of solifenacin on nocturia in Japanese patients with overactive bladder: impact on sleep evaluated by bladder diary. J Urol 186:170–174PubMedCrossRef Yokoyama O, Yamaguchi O, Kakizaki H et al (2011) Efficacy of solifenacin on nocturia in Japanese patients with overactive bladder: impact on sleep evaluated by bladder diary. J Urol 186:170–174PubMedCrossRef
18.
Zurück zum Zitat Drake NL, Flynn MK, Romero AA, Weidner AC, Amundsen CL (2005) Nocturnal polyuria in women with overactive bladder symptoms and nocturia. Am J Obstet Gynecol 192:1682–1686PubMedCrossRef Drake NL, Flynn MK, Romero AA, Weidner AC, Amundsen CL (2005) Nocturnal polyuria in women with overactive bladder symptoms and nocturia. Am J Obstet Gynecol 192:1682–1686PubMedCrossRef
19.
Zurück zum Zitat Edinger JD, Wyatt JK, Stepanski EJ et al (2011) Testing the reliability and validity of dsm-iv-tr and icsd-2 insomnia diagnoses. Results of a multitrait-multimethod analysis. Arch Gen Psychiatry 68:992–1002PubMedCrossRef Edinger JD, Wyatt JK, Stepanski EJ et al (2011) Testing the reliability and validity of dsm-iv-tr and icsd-2 insomnia diagnoses. Results of a multitrait-multimethod analysis. Arch Gen Psychiatry 68:992–1002PubMedCrossRef
20.
Zurück zum Zitat Krystal AD, Preud'homme XA, Amundsen CL, Webster GD (2010) Detrusor overactivity persisting at night and preceding nocturia in patients with overactive bladder syndrome: a nocturnal cystometrogram and polysomnogram study. J Urol 184:623–628PubMedCrossRef Krystal AD, Preud'homme XA, Amundsen CL, Webster GD (2010) Detrusor overactivity persisting at night and preceding nocturia in patients with overactive bladder syndrome: a nocturnal cystometrogram and polysomnogram study. J Urol 184:623–628PubMedCrossRef
21.
Zurück zum Zitat Weiss JP, Blaivas JG, Stember DS, Chaikin DC (1999) Evaluation of the etiology of nocturia in men: the nocturia and nocturnal bladder capacity indices. Neurourol Urodyn 18:559–565PubMedCrossRef Weiss JP, Blaivas JG, Stember DS, Chaikin DC (1999) Evaluation of the etiology of nocturia in men: the nocturia and nocturnal bladder capacity indices. Neurourol Urodyn 18:559–565PubMedCrossRef
22.
Zurück zum Zitat Weiss JP, Weinberg AC, Blaivas JG (2008) New aspects of the classification of nocturia. Curr Urol Rep 9:362–367PubMedCrossRef Weiss JP, Weinberg AC, Blaivas JG (2008) New aspects of the classification of nocturia. Curr Urol Rep 9:362–367PubMedCrossRef
23.
Zurück zum Zitat Morin CM, Bootzin RR, Buysse DJ et al (2006) Psychological and behavioral treatment of insomnia:update of the recent evidence (1998–2004). Sleep 29:1398–1414PubMed Morin CM, Bootzin RR, Buysse DJ et al (2006) Psychological and behavioral treatment of insomnia:update of the recent evidence (1998–2004). Sleep 29:1398–1414PubMed
24.
Zurück zum Zitat Morgenthaler T, Kramer M, Alessi C et al (2006) Practice parameters for the psychological and behavioral treatment of insomnia: an update. An american academy of sleep medicine report. Sleep 29:1415–1419PubMed Morgenthaler T, Kramer M, Alessi C et al (2006) Practice parameters for the psychological and behavioral treatment of insomnia: an update. An american academy of sleep medicine report. Sleep 29:1415–1419PubMed
25.
Zurück zum Zitat Ohayon MM (2008) Nocturnal awakenings and comorbid disorders in the American general population. J Psychiatr Res 43:48–54PubMedCrossRef Ohayon MM (2008) Nocturnal awakenings and comorbid disorders in the American general population. J Psychiatr Res 43:48–54PubMedCrossRef
26.
Zurück zum Zitat Kageyama T, Kabuto M, Nitta H et al (2000) Prevalence of nocturia among Japanese adults. Psychiatry Clin Neurosci 54:299–300PubMedCrossRef Kageyama T, Kabuto M, Nitta H et al (2000) Prevalence of nocturia among Japanese adults. Psychiatry Clin Neurosci 54:299–300PubMedCrossRef
27.
Zurück zum Zitat Gopal M, Sammel MD, Pien G et al (2008) Investigating the associations between nocturia and sleep disorders in perimenopausal women. J Urol 180:2063–2067PubMedCrossRef Gopal M, Sammel MD, Pien G et al (2008) Investigating the associations between nocturia and sleep disorders in perimenopausal women. J Urol 180:2063–2067PubMedCrossRef
28.
Zurück zum Zitat Chartier-Kastler E, Leger D, Montauban V, Comet D, Haab F (2009) Impact of nocturia on sleep efficiency in patients with benign prostatic hypertrophy. Prog Urol 19:333–340PubMedCrossRef Chartier-Kastler E, Leger D, Montauban V, Comet D, Haab F (2009) Impact of nocturia on sleep efficiency in patients with benign prostatic hypertrophy. Prog Urol 19:333–340PubMedCrossRef
29.
Zurück zum Zitat Ancoli-Israel S, Bliwise DL, Norgaard JP (2011) The effect of nocturia on sleep. Sleep Med Rev 15:91–97PubMedCrossRef Ancoli-Israel S, Bliwise DL, Norgaard JP (2011) The effect of nocturia on sleep. Sleep Med Rev 15:91–97PubMedCrossRef
30.
Zurück zum Zitat Irwin M, Clark C, Kennedy B, Christian Gillin J, Ziegler M (2003) Nocturnal catecholamines and immune function in insomniacs, depressed patients, and control individuals. Brain Behav Immun 17:365–372PubMedCrossRef Irwin M, Clark C, Kennedy B, Christian Gillin J, Ziegler M (2003) Nocturnal catecholamines and immune function in insomniacs, depressed patients, and control individuals. Brain Behav Immun 17:365–372PubMedCrossRef
Metadaten
Titel
Comparison of diary-derived bladder and sleep measurements across OAB individuals, primary insomniacs, and healthy controls
verfasst von
Xavier A. Preud’homme
Cindy L. Amundsen
George D. Webster
Andrew D. Krystal
Publikationsdatum
01.03.2013
Verlag
Springer-Verlag
Erschienen in
International Urogynecology Journal / Ausgabe 3/2013
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-012-1890-0

Weitere Artikel der Ausgabe 3/2013

International Urogynecology Journal 3/2013 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.